The American medical journal Immunity said that experts were able to isolate antibodies that would help in developing a combination vaccine against influenza.
Scientists at Vanderbilt University Medical Center have taken another advanced step towards preparing a combination vaccine against influenza viruses, and they have published the results of their study in this regard in the journal Immunity.
It is noteworthy that influenza B viruses (IBV) constitute a large portion of the seasonal influenza viruses circulating among humans. At the same time, current vaccines cannot stimulate the immune response against several types of viruses at the same time.
Scientists conducted an experiment by isolating antibodies from the bone marrow of a previously vaccinated person. It turns out that the FluB-400 antibody can reduce the rate of virus synthesis on human epithelial cells. After laboratory studies, tests were conducted on animals. It also confirmed that injections and nasal sprays protect against influenza B. This means that FluB-400 could form the basis for developing a combination vaccine against all types of influenza.
Wow! Impressive!
ReplyDelete